Literature DB >> 8678826

The regulation mechanism of c-jun and junB by human papillomavirus type 16 E5 oncoprotein.

S L Chen1, C H Huang, T C Tsai, K Y Lu, Y P Tsao.   

Abstract

In this study, we show that HPV-16 E5 induced anchorage-independent growth in immortalized human epidermal keratinocytes and that HPV-16 E5 in human keratinocytes had higher expression of c-jun and junB; also, we investigated the role of transcriptional initiation pathways in the expression elevation. In addition, Ras-dependent pathway, as well as PKC-dependent pathway, leads to HPV-16 E5-induced c-jun gene expression.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8678826     DOI： 10.1007/bf01718155

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


  31 in total

1.  Stable association between the bovine papillomavirus E5 transforming protein and activated platelet-derived growth factor receptor in transformed mouse cells.

Authors:  L Petti; D DiMaio
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

2.  Two AP1 sites binding JunB are essential for human papillomavirus type 18 transcription in keratinocytes.

Authors:  F Thierry; G Spyrou; M Yaniv; P Howley
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

3.  Both Jun and Fos contribute to transcription activation by the heterodimer.

Authors:  S Hirai; B Bourachot; M Yaniv
Journal:  Oncogene       Date:  1990-01       Impact factor: 9.867

Review 4.  The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation.

Authors:  P Angel; M Karin
Journal:  Biochim Biophys Acta       Date:  1991-12-10

5.  Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domain.

Authors:  B D Cohen; D J Goldstein; L Rutledge; W C Vass; D R Lowy; R Schlegel; J T Schiller
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

6.  Transforming activity of E5a protein of human papillomavirus type 6 in NIH 3T3 and C127 cells.

Authors:  S L Chen; P Mounts
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

7.  The human papillomavirus type 16 E5 gene cooperates with the E7 gene to stimulate proliferation of primary cells and increases viral gene expression.

Authors:  V Bouvard; G Matlashewski; Z M Gu; A Storey; L Banks
Journal:  Virology       Date:  1994-08-15       Impact factor: 3.616

Review 8.  MAP kinase kinase kinase, MAP kinase kinase and MAP kinase.

Authors:  C J Marshall
Journal:  Curr Opin Genet Dev       Date:  1994-02       Impact factor: 5.578

9.  The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes.

Authors:  S W Straight; P M Hinkle; R J Jewers; D J McCance
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

10.  Effects of E5a and E7 genes of human papillomavirus type 11 on immortalized human epidermal keratinocytes and NIH 3T3 cells.

Authors:  Y P Tsao; T Y Chu; T M Chen; Y F Yang; S L Chen
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574
View more
  15 in total

1.  The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated apoptosis in HaCaT cells by different mechanisms.

Authors:  Kirsten Kabsch; Angel Alonso
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Human papillomavirus type 11 and 16 E5 represses p21(WafI/SdiI/CipI) gene expression in fibroblasts and keratinocytes.

Authors:  Y P Tsao; L Y Li; T C Tsai; S L Chen
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

3.  E5 proteins of human papillomavirus types 11 and 16 transactivate the c-fos promoter through the NF1 binding element.

Authors:  S L Chen; Y K Lin; L Y Li; Y P Tsao; H Y Lo; W B Wang; T C Tsai
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

4.  Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses.

Authors:  Zigui Chen; Masanori Terai; Leiping Fu; Rolando Herrero; Rob DeSalle; Robert D Burk
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

Review 5.  Modulation of apoptosis by human papillomavirus (HPV) oncoproteins.

Authors:  T O Garnett; P J Duerksen-Hughes
Journal:  Arch Virol       Date:  2006-07-27       Impact factor: 2.574

6.  Cytotoxic-T-lymphocyte human papillomavirus type 16 E5 peptide with CpG-oligodeoxynucleotide can eliminate tumor growth in C57BL/6 mice.

Authors:  Yi-Fang Chen; Chih-Wei Lin; Yeou-Ping Tsao; Show-Li Chen
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

7.  Human papillomavirus 16 E5 oncogene contributes to two stages of skin carcinogenesis.

Authors:  John P Maufort; Sybil M Genther Williams; Henry C Pitot; Paul F Lambert
Journal:  Cancer Res       Date:  2007-07-01       Impact factor: 12.701

Review 8.  The E5 proteins.

Authors:  Daniel DiMaio; Lisa M Petti
Journal:  Virology       Date:  2013-05-31       Impact factor: 3.616

Review 9.  The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation.

Authors:  James A Scarth; Molly R Patterson; Ethan L Morgan; Andrew Macdonald
Journal:  J Gen Virol       Date:  2021-01-11       Impact factor: 3.891

Review 10.  Aristocratic human papillomavirus drove cervical cancer: a study of the therapeutic potential of the combination of interferon with zinc.

Authors:  Yun-He Gao; Lei Yu; Zhong-Shan Liu; Yun-Feng Li
Journal:  Mol Cell Biochem       Date:  2020-10-24       Impact factor: 3.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.